Margaret Gatti-Mays

Assistant Professor

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Mary L. (Nora) Disis

Associate Dean

University of Washington

UNITED STATES

View details

Marijo Bilusic

Professor/ GU Oncology Team Lead

Sylvester Comprehensive Cancer Center, University of Miami

UNITED STATES

View details

Tyler Curiel

Gmelich Professor of Cancer Immunotherapy

Dartmouth-Hitchcock Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Margaret Gatti-Mays

Research Interests

Explore related searches

Contact this professor

Articles (10)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer

A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors

Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer

Improving Breast Cancer Responses to Immunotherapy—a Search for the Achilles Heel of the Tumor Microenvironment

Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis

A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib ( LY2606368 ) in BRCA Wild‐Type , Advanced Triple‐Negative Breast Cancer

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

Collaborators (3)

Mary L. (Nora) Disis

Marijo Bilusic

Tyler Curiel

Make your next move.